Malignant Peritoneal Mesothelioma research hub

Phase II multicenter randomized trial evaluating the association of PIPAC and systemic chemotherapy versus systemic chemotherapy alone as 1st-line treatment of Malignant Peritoneal Mesothelioma

This study is looking at a new way to treat a type of cancer called malignant peritoneal mesothelioma. It compares standard chemotherapy with chemotherapy plus a special treatment called PIPAC to see if it works better for people recently diagnosed.